Back to results
US 2022/0031846 A1Published application
Animal protein-free pharmaceutical compositions
AssigneeAllergan, Inc.
InventorTerrence J. Hunt
Life of this patent
Estimating the term…
Abstract
Animal protein-free, solid-form Clostridial toxin pharmaceutical compositions comprising a Clostridial toxin active ingredient and at least two excipients.
Claims20
A method to stabilize a Clostridial neurotoxin, comprising:
- providing an aqueous solution comprising a Clostridial neurotoxin and a non-mammalian protein excipient;
- and
- compounding the solution with one or more additional non-protein excipients to provide a formulation comprising the neurotoxin in stable form.
A powder pharmaceutical composition, comprising:
- a botulinum toxin, wherein the botulinum toxin is a type A serotype;
- a surfactant;
- at least one disaccharide selected from the group consisting of sucrose and trehalose;
- and
- a buffer sufficient to maintain a pH of from about 5 to about 7.3 upon reconstitution with sterile normal saline or water;
- wherein the composition is suitable for intramuscular or subcutaneous injection following reconstitution with sterile normal saline or water,
- wherein the composition is animal protein free, and
- wherein the composition retains at least about 75% of the theoretical maximum potency of the botulinum toxin following storage as a powder for three months at room temperature.
5 more elements
A powder pharmaceutical composition, comprising:
- a 150 kD botulinum toxin, wherein the botulinum toxin is a serotype A;
- a surfactant;
- about 5 mg to about 250 mg of sucrose or trehalose for each about 100 units of the botulinum toxin;
- and
- a buffer sufficient to maintain a pH of from about 5.5 to about 6.5 upon reconstitution with sterile normal saline or water;
- wherein the composition is suitable for intramuscular or subcutaneous injection following reconstitution with sterile normal saline or water,
- wherein the composition is animal protein free, and
- wherein the composition retains at least about 75% of the theoretical maximum potency of the botulinum toxin following storage as a powder for three months at room temperature.
5 more elements
Dependencies are inferred from the claim text.